INF2 and focal segmental glomerulosclerosis: INF2 mutations causing the dual CMT–FSGS diseases exclusively cluster within residues 57 to 184 of the DID domain, which likely impedes the intramolecular binding DID–DAD interaction [4,5,6,8].